Medipharm Labs Corp
TSX:LABS

Watchlist Manager
Medipharm Labs Corp Logo
Medipharm Labs Corp
TSX:LABS
Watchlist
Price: 0.075 CAD Market Closed
Market Cap: 31.6m CAD

Medipharm Labs Corp
Other

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Medipharm Labs Corp
Other Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other CAGR 3Y CAGR 5Y CAGR 10Y
Medipharm Labs Corp
TSX:LABS
Other
CA$244k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bausch Health Companies Inc
TSX:BHC
Other
-$110m
CAGR 3-Years
7%
CAGR 5-Years
2%
CAGR 10-Years
9%
Canopy Growth Corp
TSX:WEED
Other
-CA$24.5m
CAGR 3-Years
-101%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sundial Growers Inc
NASDAQ:SNDL
Other
CA$957k
CAGR 3-Years
-81%
CAGR 5-Years
-60%
CAGR 10-Years
N/A
Cronos Group Inc
TSX:CRON
Other
-$7.3m
CAGR 3-Years
-4%
CAGR 5-Years
-171%
CAGR 10-Years
-18%
K
Knight Therapeutics Inc
TSX:GUD
Other
-CA$6.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-37%

Medipharm Labs Corp
Glance View

Market Cap
31.1m CAD
Industry
Pharmaceuticals

MediPharm Labs Corp. is medicinal cannabis company, which engages in the pharmaceutical grade production of cannabis oil products. The company is headquartered in Barrie, Ontario and currently employs 190 full-time employees. The company went IPO on 2018-02-09. The firm produces purified, pharmaceutical-like cannabis extracts and related derivative products. The firm formulates, processes, packages and distributes cannabis extracts and cannabinoid-based products at its Canadian and Australian facilities for domestic and international markets. The Company, through its subsidiaries is engaged in the sale and distribution of cannabis oil, cannabis extracts, cannabis edibles, cannabis topicals, and derivatives to authorized classes of purchasers, as well as controlled human administration trials for sensory testing of cannabis extracts and derivative products. The company is also engaged in the manufacturing of extracts and tinctures of cannabis and cannabis resin for the purpose of a clinical trial or prescribed as medical cannabis products. The firm's wholly owned subsidiaries include MediPharm Labs Inc. and MediPharm Labs Australia Pty. Ltd.

LABS Intrinsic Value
0.097 CAD
Undervaluation 23%
Intrinsic Value
Price

See Also

What is Medipharm Labs Corp's Other?
Other
244k CAD

Based on the financial report for Mar 31, 2025, Medipharm Labs Corp's Other amounts to 244k CAD.

What is Medipharm Labs Corp's Other growth rate?
Other CAGR 1Y
-54%

Over the last year, the Other growth was -54%.

Back to Top